Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CVAC - Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?

CVAC - Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?

CureVac N.V.

CureVac (NASDAQ: CVAC) recently announced that Boehringer Ingelheim terminated a partnership on a messenger RNA lung cancer vaccine program. In this Motley Fool Live video recorded on Aug. 18 , Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not this canceled deal spells trouble for other mRNA cancer vaccines in development.

Continue reading

For further details see:

Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
Stock Information
Company Name: CureVac N.V.
Stock Symbol: CVAC
Market: NASDAQ
Website: curevac.com
Menu
CVAC CVAC Quote CVAC Short CVAC News CVAC Articles CVAC Message Board
Get CVAC Alerts

News, Short Squeeze, Breakout and More Instantly...